tiprankstipranks
Trending News
More News >
Protagonist Therapeutics (PTGX)
NASDAQ:PTGX

Protagonist Therapeutics (PTGX) Revenue

Compare
663 Followers

Protagonist Therapeutics Revenue

Protagonist Therapeutics had a revenue of 28.32M in the quarter ending Mar 31, 2025, with -83.40%. This bring the company's revenue in the last twelve months to 207.80M, Increased -52.17%. In the fiscal year ending Dec 31, 2024, Protagonist Therapeutics had annual revenue of 434.43M with 624.05% growth.
Revenue (ttm)
207.80M
Revenue Growth
-34.02%
P/S Ratio
7.77
Revenue/Employee
$3,503,492
Employees
124
Market Cap
$3.37B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
434.43M374.43M+624.06%
Dec 31, 2023
60.00M33.42M+125.73%
Dec 31, 2022
26.58M-776.00K-2.84%
Dec 31, 2021
27.36M-1.27M-4.44%
Dec 31, 2020
28.63M28.40M+12,293.07%
Dec 31, 2019
231.00K-30.69M-99.25%
Dec 31, 2018
30.93M10.86M+54.14%
Dec 31, 2017
20.06M+∞%
Dec 31, 2016
0.00
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis